We are rare individuals who follow the ever-changing anatomy of pharmaceutical regulations with the same intensity that others track presidential electoral politics. Our understanding, our obsession with the regulatory environment has saved North American and European clients’ money, time and aggravation in launching new products that comply with FDA regulations.
The acronym for Regulatory Affairs, North America is RANA. Like the frog genus RANA, we are no strangers to science. We can dissect the most complex problems, catch solutions on the fly and are bellweathers in any regulatory environment.